青少年和年轻成人(AYA)与老年癌症患者对早期临床试验态度的问卷研究比较
该问卷研究在英格兰西北部一家区域癌症中心开展,比较16-24岁AYA癌症患者与25岁及以上老年患者对早期临床试验的态度。AYA组50人、非AYA组51人完成问卷,ACTS-CT量表在个人获益和个人与社会价值类别存在显著差异,附加条目中谁接触患者、对短期和长期目标影响的担忧及感到不堪重负方面也有显著差异,个人障碍及研究过程的安全与信任类别无显著差异。
要点
- AYA组与非AYA组在个人获益(p=0.000)和个人与社会价值(p=0.001)类别存在显著差异。
- 谁接触患者的重要性、对短期目标影响(p=0.005)、长期目标影响(p=0.000)及感到不堪重负(p=0.000)有显著差异。
- 个人障碍及研究过程的安全与信任类别无显著差异。
核心结论
- 理解AYA患者的态度和担忧对于制定以患者为中心的临床试验参与方法至关重要。
- 研究识别出AYA与老年患者观点上的显著差异,可用于解决该群体的不平等问题。
研究设计与样本
- 该研究为基于问卷的研究,在英格兰西北部一家区域癌症中心开展。
- 纳入既往诊断为癌症且处于随访、正在接受治疗或正在考虑治疗的患者。
- 通过Qualtrics™工具在线收集回答,结局指标为ACTS-CT量表的癌症治疗子量表及Lewin等(2020)试点内容和效度的九个附加问题。
主要发现
- AYA组50人(64%女性)和非AYA组51人(43%女性)完成了至少部分问卷。
- AYA受访者在参与时和初诊时多数为19-24岁(分别为62%和50%),非AYA受访者多数为30岁及以上(88%)。
- AYA组最常见诊断为淋巴瘤(46%),非AYA组为癌(43%)。
- AYA组与非AYA组在个人获益(p=0.000)和个人与社会价值(p=0.001)类别存在显著差异。
- 附加条目中谁接触患者的重要性(p=0.000)、对短期目标影响的担忧(p=0.005)、对长期目标影响的担忧(p=0.000)及感到不堪重负(p=0.000)存在显著差异。
关键数值与推荐
- ACTS-CT量表的个人获益类别AYA组与非AYA组差异p=0.000。
- 个人与社会价值类别AYA组与非AYA组差异p=0.001。
- 谁接触患者的重要性AYA组与非AYA组差异p=0.000。
- 对短期目标影响的担忧AYA组与非AYA组差异p=0.005。
- 对长期目标影响的担忧AYA组与非AYA组差异p=0.000;感到不堪重负AYA组与非AYA组差异p=0.000。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Adolescent and young adults (AYA) with cancer are poorly recruited to early phase clinical trials compared to older adult patients, contributing to a slower improvement in survival outcomes. To overcome this, we need to better understand the barriers to recruitment. This study aimed to explore the attitudes of AYA with cancer (aged 16-24) towards clinical trials, compared with those of older patients (aged 25 and over). METHODS: This questionnaire-based study was conducted in a regional cancer centre in North-West England. Participants were eligible if they were previously diagnosed with cancer, and either in follow up, receiving or being considered for treatment. Responses were collected online using the Qualtrics™ tool. The outcome measure was the Cancer Treatment sub-scale of the Attitudes Toward Cancer Trials Scales (ACTS-CT), and nine additional questions as piloted for content and validity by Lewin et al. (2020). RESULTS: Fifty AYA [64% female] and 51 non-AYA [43% female] completed at least part of the questionnaire. At both participation and at initial diagnosis, most AYA respondents were aged 19-24 [62% and 50% respectively], while most non-AYA respondents were 30 or over [88%]. The most common diagnosis in AYA was lymphoma [46%], while in non-AYA it was carcinoma [43%]. Significant differences were observed between AYA and non-AYA participants in the personal benefits (p = 0.000) and personal and social value (p = 0.001) categories, and four of the additional statements including the importance of who approaches the patient (p = 0.000), concerns about the impact of trials on short term (p = 0.005) and long-term goals (p = 0.000), and feeling too overwhelmed to participate in a trial (p = 0.000). No significant differences were found in the personal barriers and safety and trust in the research process categories. CONCLUSIONS: Understanding the attitudes and concerns of AYA patients is crucial for the development of patient-centered approaches to clinical trial participation in this population. Here, we identified notable differences in the perspectives of AYA versus older patients that can be used to address inequalities in this group.
引用
- Johnston E, McCabe M, Carter L, et al. A questionnaire study comparing the attitudes of adolescents and young adults (AYA) and older adult cancer patients towards early phase clinical trials. Trials. 2025. PMID: 41219764. doi:10.1186/s13063-025-09069-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。